Search Results - "Shackleford, Terry J."
-
1
JAB1/CSN5: a new player in cell cycle control and cancer
Published in Cell division (18-10-2010)“…c-Jun activation domain-binding protein-1 (Jab1) acts as a modulator of intracellular signaling and affects cellular proliferation and apoptosis, through its…”
Get full text
Journal Article -
2
Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells
Published in Breast cancer research : BCR (20-06-2011)“…The c-Jun coactivator, Jun activation-domain binding protein 1 (Jab1) also known as the fifth component of the COP9 signalosome complex (CSN5), is a novel…”
Get full text
Journal Article -
3
Redundant Signaling as the Predominant Mechanism for Resistance to Antibodies Targeting the Type-I Insulin-Like Growth Factor Receptor in Cells Derived from Childhood Sarcoma
Published in Molecular cancer therapeutics (03-04-2023)“…Antibodies targeting insulin-like growth factor 1 receptor (IGF-1R) induce objective responses in only 5% to 15% of children with sarcoma. Understanding the…”
Get full text
Journal Article -
4
Vertical Inhibition of the RAF-MEK-ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRAS Q61X Mutant Rhabdomyosarcoma
Published in Molecular cancer therapeutics (01-01-2022)“…Oncogenic RAS signaling is an attractive target for fusion-negative rhabdomyosarcoma (FN-RMS). Our study validates the role of the ERK MAPK effector pathway in…”
Get full text
Journal Article -
5
Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in H/NRASQ61X Mutant Rhabdomyosarcoma
Published in Molecular cancer therapeutics (01-01-2022)“…Abstract Oncogenic RAS signaling is an attractive target for fusion-negative rhabdomyosarcoma (FN-RMS). Our study validates the role of the ERK MAPK effector…”
Get full text
Journal Article -
6
Effect of low-fat diets on plasma levels of NF-κB-regulated inflammatory cytokines and angiogenic factors in men with prostate cancer
Published in Cancer prevention research (Philadelphia, Pa.) (01-10-2011)“…Diet, nutritional status, and certain dietary supplements are postulated to influence the development and progression of prostate cancer. Angiogenesis and…”
Get full text
Journal Article -
7
Abstract 5825: Mechanisms of intrinsic and acquired resistance to antibodies targeting IGF-1R in pediatric sarcoma cell lines
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Background: Pediatric bone and soft tissue sarcomas are heavily dependent on the Type 1 insulin-like growth factor receptor (IGF-1R) signaling axis,…”
Get full text
Journal Article -
8
Abstract 2472: Mechanisms of resistance to IGFR-targeted therapy in pediatric sarcomas
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Background: Insulin-like growth factor-I receptor (IGFR) signaling promotes tumorigenic properties which makes targeting IGFR an attractive…”
Get full text
Journal Article -
9
Abstract 1825: Jab1/Csn5 a new target in the resistant mechanism to HER2-targeted therapies for breast cancer
Published in Cancer research (Chicago, Ill.) (01-10-2014)“…Abstract Her2 positive (Her2+) breast cancer (BC) accounts for 20% of all breast cancer subtypes and is associated with high risk of death. Trastuzumab (Ttzm),…”
Get full text
Journal Article -
10
Abemaciclib is Active in Preclinical Models of Ewing's Sarcoma via Multi-pronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway Signaling
Published in Clinical cancer research (21-08-2018)“…Ewing's sarcoma (ES) is a rare and highly malignant cancer that occurs in the bone and surrounding tissue of children and adolescents. The EWS/ETS fusion…”
Get full text
Journal Article -
11
Abstract B231: Jab1/Csn5 a new player driving the resistance to Her2-targeted therapies for breast cancer
Published in Molecular cancer therapeutics (01-11-2013)“…Abstract Her2 a key member in the epidermal growth factor receptor (EGFR) family, is one of the most dominant oncogenes in breast cancer. It is overexpressed…”
Get full text
Journal Article -
12
Abstract PR-09: Low-fat diet reduces NF-κB regulated inflammatory cytokines and angiogenic factors in plasma of men with prostate cancer
Published in Cancer prevention research (Philadelphia, Pa.) (01-12-2010)“…Abstract Purpose: Diet and certain dietary supplements are postulated to influence the development and progression of prostate cancer. Angiogenesis and…”
Get full text
Journal Article